Feed Articles

CVS split: a step towards a better future?

CVS Health, one of the largest healthcare players in the United States, is facing a potential major change. The company is considering splitting its core divisions - retail pharmacy and insurance - in response to financial challenges and pressure from investors. The move could fundamentally affect the direction the company takes and open the door to a new era of its operations.

The contemplated demerger

In recent weeks, CVS management has discussed several options for reshaping its structure. Among them is a plan to separate the retail pharmacy network from the insurance division, which includes Aetna, CVS's key 2017 acquisition. Discussions with financial advisors are still ongoing and a final decision has not yet been made, but the plan has already been presented to the board.

An important question in the process is where the pharmacy benefits manager (PBM) division, which handles benefits administration for health plans, should fall. One option is to put it under the retail division, the other is to put it under the insurance division if the company were to be split into two separate companies.

Investor pressure and economic challenges

The decision on a possible split is not random. CVS is currently facing one of the most difficult periods in its 60-year history. The company has experienced a decline in profits, with its stock down nearly a quarter of its value since the beginning of 2023. The situation has been further exacerbated by the departure of Aetna CEO Brian Kane, who had to leave due to poor results in Medicare, where health care costs are rising.

Other health insurers, such as UnitedHealth and Humana, are also under pressure as they also face rising costs. However, investors such as Glenview Capital are putting pressure on CVS to look for ways to increase efficiency and improve its results.

Historical roots and current challenges

CVS was founded in 1963 as a chain of pharmacies and has grown over time into a giant healthcare company with more than 9,000 locations across the United States. Its expansion has been through major acquisitions such as Caremark, Medicare home care provider Signify Health, and Oak Street Health, which focuses on primary care for Medicare patients.

Although CVS is known primarily for its pharmacy network, many analysts believe that this division has become the company's weakest link. Unless there is a major transformation, such as an expansion of medical services provided directly at these pharmacies, the company will be forced to make strategic changes to maintain its competitiveness.

Splitting CVS Health would be a step back from its key move, which was the acquisition of Aetna, but it could also be a solution for future growth. The company's management recognizes the need to improve performance and is always looking for ways to maximize value for its shareholders. Therefore, the future of CVS will depend on the company's ability to respond effectively to rising costs and adapt to the new demands of the healthcare market.

Disclaimer: You will find a lot of inspiration on Bulios, but stock selection and portfolio construction is up to you, so always conduct a thorough analysis of your own.

Source: CNN, Investing.com, Yahoo.

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy